Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03725345 · ClinicalTrials.gov registry record · NA

Genetic and Neural Factors in Alcohol-Related Cognition

A NA study of Alcohol Abuse, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT03725345: Completed NA study of Alcohol Abuse, sponsored by Virginia Commonwealth University.

NCT03725345 is a NA study of Alcohol Abuse that has completed, run by Virginia Commonwealth University. The registered enrollment target is 9 participants, below the 713-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03725345, a NA study of Alcohol Abuse, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

This study examines the genetic factors that impact cognitive processes and behavior after alcohol consumption. Participation in this project will contribute to a better understanding of cognitive factors that influence alcohol misuse.

Primary Outcome

Aggressive behavior (i.e., the average volume of noise blasts selected to be administered to participants' opponents) after recent consumption of an alcoholic beverages (versus without recent consumption of an alcoholic beverages) will be measured using the validated and computerized Taylor Competitive Reaction-Time Task. The Taylor Competitive Reaction-Time Task consists of multiple trials that each assess aggression, via a four-point scale that ranges from 1 (low noise blast volume \[low aggre

Conditions Studied

Interventions

  • BEHAVIORAL MRI Scanner

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2023-07-11
Est. Completion 2024-11-01
Phase NA
Virginia Commonwealth University

558 total trials

What the finished NCT03725345 record still lists

NCT03725345 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 713-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Alcohol Abuse appearing as the primary indexed condition, and to 1 intervention - of which MRI Scanner is the first listed.

NCT03725345 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT03725345 about?

NCT03725345 is a clinical study titled "Genetic and Neural Factors in Alcohol-Related Cognition". This study examines the genetic factors that impact cognitive processes and behavior after alcohol consumption. Participation in this project will contribute to a better understanding of cognitive factors that influence alcohol misuse.

What is the current status of trial NCT03725345?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2023-07-11. Estimated completion is 2024-11-01.

What conditions does trial NCT03725345 study?

This clinical trial studies the following conditions: Alcohol Abuse.

What interventions are being tested in trial NCT03725345?

The interventions under investigation include: MRI Scanner (BEHAVIORAL).

Who is sponsoring clinical trial NCT03725345?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03725345 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03725345's enrollment target sits among peer trials

9 47th of 46 the lowest of 46 other Alcohol Abuse trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alcohol Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03725345, the US trial registry maintained by the National Library of Medicine. NCT03725345 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.